284 related articles for article (PubMed ID: 17195151)
1. Serum caffeine concentrations in preterm neonates.
Leon AE; Michienzi K; Ma CX; Hutchison AA
Am J Perinatol; 2007 Jan; 24(1):39-47. PubMed ID: 17195151
[TBL] [Abstract][Full Text] [Related]
2. Caffeine versus theophylline for apnea of prematurity: a randomised controlled trial.
Skouroliakou M; Bacopoulou F; Markantonis SL
J Paediatr Child Health; 2009 Oct; 45(10):587-92. PubMed ID: 19751376
[TBL] [Abstract][Full Text] [Related]
3. Caffeine therapy for apnea of prematurity.
Schmidt B; Roberts RS; Davis P; Doyle LW; Barrington KJ; Ohlsson A; Solimano A; Tin W;
N Engl J Med; 2006 May; 354(20):2112-21. PubMed ID: 16707748
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics of intravenous caffeine in neonates with apnea of prematurity.
Lee TC; Charles B; Steer P; Flenady V; Shearman A
Clin Pharmacol Ther; 1997 Jun; 61(6):628-40. PubMed ID: 9209245
[TBL] [Abstract][Full Text] [Related]
5. Correlation between plasma and urinary caffeine levels in preterm infants.
Cattarossi L; Violino M; Macagno F; Logreco P; Savoia M
J Perinat Med; 2006; 34(4):344-6. PubMed ID: 16856829
[TBL] [Abstract][Full Text] [Related]
6. Caffeine in the treatment of apnea associated with respiratory syncytial virus infection in neonates and infants.
Tobias JD
South Med J; 2000 Mar; 93(3):294-6. PubMed ID: 10728517
[TBL] [Abstract][Full Text] [Related]
7. Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring.
Charles BG; Townsend SR; Steer PA; Flenady VJ; Gray PH; Shearman A
Ther Drug Monit; 2008 Dec; 30(6):709-16. PubMed ID: 19057373
[TBL] [Abstract][Full Text] [Related]
8. Influence of prevention of caffeine citrate on cytokine profile and bronchopulmonary dysplasia in preterm infants with apnea.
Kou C; Han D; Li Z; Wu W; Liu Z; Zhang Y; Gao Z
Minerva Pediatr; 2020 Apr; 72(2):95-100. PubMed ID: 30961342
[TBL] [Abstract][Full Text] [Related]
9. Periextubation caffeine in preterm neonates: a randomized dose response trial.
Steer PA; Flenady VJ; Shearman A; Lee TC; Tudehope DI; Charles BG
J Paediatr Child Health; 2003; 39(7):511-5. PubMed ID: 12969204
[TBL] [Abstract][Full Text] [Related]
10. Incorporating pharmacodynamic considerations into caffeine therapeutic drug monitoring in preterm neonates.
Yu T; Balch AH; Ward RM; Korgenski EK; Sherwin CM
BMC Pharmacol Toxicol; 2016 Jun; 17(1):22. PubMed ID: 27266401
[TBL] [Abstract][Full Text] [Related]
11. Caffeine Citrate Dosing Adjustments to Assure Stable Caffeine Concentrations in Preterm Neonates.
Koch G; Datta AN; Jost K; Schulzke SM; van den Anker J; Pfister M
J Pediatr; 2017 Dec; 191():50-56.e1. PubMed ID: 29173321
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of percutaneous caffeine in the treatment of apnea in the premature infant].
Morisot C; Simoens C; Trublin F; Lhermitte M; Gremillet C; Robert MH; Lequien P
Arch Fr Pediatr; 1990 Mar; 47(3):221-4. PubMed ID: 2344252
[TBL] [Abstract][Full Text] [Related]
13. Saliva as a valid alternative to serum in monitoring intravenous caffeine treatment for apnea of prematurity.
Lee TC; Charles BG; Steer PA; Flenady VJ
Ther Drug Monit; 1996 Jun; 18(3):288-93. PubMed ID: 8738770
[TBL] [Abstract][Full Text] [Related]
14. High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial.
Mohammed S; Nour I; Shabaan AE; Shouman B; Abdel-Hady H; Nasef N
Eur J Pediatr; 2015 Jul; 174(7):949-56. PubMed ID: 25644724
[TBL] [Abstract][Full Text] [Related]
15. Caffeine for apnea of prematurity.
Hand IL; Noble LM
N Engl J Med; 2006 Aug; 355(9):959; author reply 959-60. PubMed ID: 16948188
[No Abstract] [Full Text] [Related]
16. Postoperative recovery after inguinal herniotomy in ex-premature infants and the use of caffeine.
Choi DM; Davis L
Br J Anaesth; 2002 Feb; 88(2):301; author reply 301. PubMed ID: 11883390
[No Abstract] [Full Text] [Related]
17. Caffeine impact on neonatal morbidities.
Aranda JV; Beharry K; Valencia GB; Natarajan G; Davis J
J Matern Fetal Neonatal Med; 2010 Oct; 23 Suppl 3():20-3. PubMed ID: 20873976
[TBL] [Abstract][Full Text] [Related]
18. Caffeine Administration to Prevent Apnea in Very Premature Infants.
Armanian AM; Iranpour R; Faghihian E; Salehimehr N
Pediatr Neonatol; 2016 Oct; 57(5):408-412. PubMed ID: 26976495
[TBL] [Abstract][Full Text] [Related]
19. Caffeine for apnea of prematurity.
Bancalari E
N Engl J Med; 2006 May; 354(20):2179-81. PubMed ID: 16707756
[No Abstract] [Full Text] [Related]
20. Caffeine Therapy in Preterm Infants: The Dose (and Timing) Make the Medicine.
Rostas SE; McPherson C
Neonatal Netw; 2019 Nov; 38(6):365-374. PubMed ID: 31712401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
